Activity of cefepime compared with other antibiotics against gram- positive bacteria and cefuroxime-resistant Gram-negative bacteria

Chinese Medical Journal (Taipei)

Volumn 61, Issue 7, 1998, Pages 408-413

  Wang, Fu Der ^a,b   Liu, Ing Ming ^a   Liu, Cheng Yi ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antibiotic activity; Cefepime; Gram negative bacilli; Gram positive cocci

Indexed keywords

CEFEPIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; IMIPENEM;

ACINETOBACTER; AGAR GEL DIFFUSION; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BURKHOLDERIA CEPACIA; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STREPTOCOCCUS PYOGENES;

CEFUROXIME; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0031903904     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Barradell LB, Bryson HM. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;47:471-505.
2. Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA. Cefepime: a new fourth generation cephalosporin. Am J Hosp Pharm 1994;51:463-77.
3. Cunha BA, Gill MV. Cefepime. Med Clin North Am 1995;79:721-32.
4. Fekete T, Tumah H, Woodwell J, Satishchandran V, Truant A, Axelrod P. Comparative susceptibilities of Klebsiella species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospital. Am J Med 1996;100(suppl 6A):20-5.
5. Thornsberry C, Yee C. Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods. Am J Med 1996;100(suppl 6A):26-38.
6. Jorgensen JH, Cleeland R, Craig WA, Doern GV, Ferraro MJ, Finegold SM, et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 3rd ed: approved standard M7-A3. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993;13: 1-27.
7. Jorgensen JH, Craig WA, Doern GV, Ferraro MJ, Finegold SM, Fung-Tomc J, et al. Performance Standards for Antimicrobial Susceptibility Testing, Sixth Informational Supplement. NCCLS document M100-S6. National Committee for Clinical Laboratory Standards, 1995;15:1-13.
8. Jones RN, Marshall SA. Antimicrobial activity of cefepime tested against Bush group 1 β-lactamase-producing strains resistant to ceftazidime. Diagn Microbial Infect Dis 1994; 19:33-8.
9. Kessler RE, Fung-Tomc J. Susceptibility of bacterial isolates to β-lactam antibiotics from US clinical trials over a 5-year period. Am J Med 1996;100(suppl 6A):13-9.
10. Hsieh WC, Chang SC, Luh KT, Ho SW. Antimicrobial activities of seven new beta-lactam antibiotics. J Formosan Med Assoc 1988;87:554-8.